These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


86 related items for PubMed ID: 230893

  • 1. Treatment of grade III and IV astrocytomas with BCNU alone and in combination with VM-26 following surgery and radiation therapy.
    Sweet DL, Hendler FJ, Hanlon K, Hekmatpanah J, Griem ML, Duda EE, Mulligan B, Wollman RL.
    Cancer Treat Rep; 1979; 63(11-12):1707-11. PubMed ID: 230893
    [Abstract] [Full Text] [Related]

  • 2. Adjuvant chemotherapy with VM 26 and CCNU after operation and radiotherapy of high-grade supratentorial astrocytomas.
    Seiler RW, Zimmermann A, Markwalder H.
    Surg Neurol; 1980 Jan; 13(1):65-8. PubMed ID: 6244679
    [Abstract] [Full Text] [Related]

  • 3. Controlled study with BCNU vs. CCNU as adjuvant chemotherapy following surgery plus radiotherapy for glioblastoma multiforme.
    Solero CL, Monfardini S, Brambilla C, Vaghi A, Valagussa P, Morello G, Bonadonna G.
    Cancer Clin Trials; 1979 Jan; 2(1):43-8. PubMed ID: 229983
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine.
    Selker RG, Shapiro WR, Burger P, Blackwood MS, Arena VC, Gilder JC, Malkin MG, Mealey JJ, Neal JH, Olson J, Robertson JT, Barnett GH, Bloomfield S, Albright R, Hochberg FH, Hiesiger E, Green S, Brain Tumor Cooperative Group.
    Neurosurgery; 2002 Aug; 51(2):343-55; discussion 355-7. PubMed ID: 12182772
    [Abstract] [Full Text] [Related]

  • 8. Sequential and adjuvant chemotherapy for malignant astrocytoma of the brain.
    Kessinger A, Lemon HM, Foley JF.
    J Surg Oncol; 1978 Aug; 10(6):543-7. PubMed ID: 215846
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combination chemotherapy with VM 26 and CCNU in primary malignant brain tumors of children.
    Seiler RW.
    Helv Paediatr Acta; 1980 Mar; 35(1):51-6. PubMed ID: 7410103
    [Abstract] [Full Text] [Related]

  • 13. Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma.
    Green SB, Byar DP, Walker MD, Pistenmaa DA, Alexander E, Batzdorf U, Brooks WH, Hunt WE, Mealey J, Odom GL, Paoletti P, Ransohoff J, Robertson JT, Selker RG, Shapiro WR, Smith KR, Wilson CB, Strike TA.
    Cancer Treat Rep; 1983 Feb; 67(2):121-32. PubMed ID: 6337710
    [Abstract] [Full Text] [Related]

  • 14. Combined chemotherapy with VM 26 and BCNU for recurrent malignant gliomas after operation and irradiation.
    Zander E, de Tribolet N, Wagenknecht L.
    Acta Neurochir (Wien); 1978 Feb; 42(1-2):97-101. PubMed ID: 696446
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Individualized therapy and outcomes of microsurgery, radiotherapy, and chemotherapy for astrocytoma].
    Zhou WN, Chen ZP, You C, Mu YG, Sai K, Zhang JY, Zhang XH, Cheng JJ, Xu HC.
    Ai Zheng; 2004 Nov; 23(11 Suppl):1555-60. PubMed ID: 15566679
    [Abstract] [Full Text] [Related]

  • 19. BCNU-DBD (Dibromodulcitol) chemotherapy of recurrent supratentorial anaplastic astrocytomas and glioblastomas.
    Vitanovics D, Sipos L, Afra D.
    Neoplasma; 2002 Nov; 49(5):342-5. PubMed ID: 12458335
    [Abstract] [Full Text] [Related]

  • 20. VM-26 as a second drug in the treatment of brain gliomas.
    Kessinger A, Lemon HM, Foley JF.
    Cancer Treat Rep; 1979 Mar; 63(3):511-2. PubMed ID: 427830
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.